Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre L Levy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Cell|May 10, 2022
Fast track to personalized TCR T cell therapiesPierre L Levy, Alena Gros
Viruses|March 23, 2013
Hepatitis C virus-induced mitochondrial dysfunctionsCharlène Brault, Pierre L Levy, Birke Bartosch
Journal for Immunotherapy of Cancer|November 7, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunctionDavid W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, et al.
Cancer Cell|March 15, 2024
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitnessChun-Pu Lin, Pierre L Levy, Astrid Alflen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Cell|May 10, 2022
Fast track to personalized TCR T cell therapiesPierre L Levy, Alena Gros
Viruses|March 23, 2013
Hepatitis C virus-induced mitochondrial dysfunctionsCharlène Brault, Pierre L Levy, Birke Bartosch
Journal for Immunotherapy of Cancer|November 7, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunctionDavid W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, et al.
Cancer Cell|March 15, 2024
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitnessChun-Pu Lin, Pierre L Levy, Astrid Alflen, et al.
Pageof 1